Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease

References

• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report [Internet]. Global Initiative Chronic Obstructive Lung Dis. 2020. https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf
   Google Scholar
• McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA, Committee TCE. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007;62(5):1–6. doi:10.1136/thx.2006.072348.
   Web of Science ®Google Scholar
• National Center for Immunization and Respiratory Diseases. Pneumococcal vaccination: information for healthcare professionals; [ updated 2019 Dec 9]. https://www.cdc.gov/vaccines/vpd/pneumo/hcp/index.html.
   Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices — United States, 2019–20 influenza season. https://www.cdc.gov/mmwr/volumes/68/rr/rr6803a1.htm?s_cid=rr6803a1_w.
   Google Scholar
• World Health Organization. Chronic obstructive pulmonary disease (COPD); 2022 [ updated 2022 May 20; accessed 2022 June 13]. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-copd.
   Google Scholar
• Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest. 2004;125:2011–2020. doi:10.1378/chest.125.6.2011.
   PubMed Web of Science ®Google Scholar
• Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. J Med Assoc Thai. 2003;86:497–508.
   PubMedGoogle Scholar
• Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax. 2009;64(7):567–572. doi:10.1136/thx.2008.106286.
   PubMed Web of Science ®Google Scholar
• Aka Akturk U, Gorek Dilektasli A, Sengul A, Musaffa Salepci B, Oktay N, Duger M, Arık Taşyıkan H, Durmuş Koçak N. Influenza and pneumonia vaccination rates and factors affecting vaccination among patients with chronic obstructive pulmonary disease. Balkan Med J. 2017;34(3):206–211. doi:10.4274/balkanmedj.2016.1028.
   PubMed Web of Science ®Google Scholar
• Prasert K, Patumanond J, Rattanayot J, Thungthong J, Shrestha M, Chawalchitiporn S, et al. Seasonal influenza vaccine effectiveness among individuals with COPD in Thailand: a retrospective national cohort study of 2011-2013 influenza seasons. J Public Hlth Dev. 2021;19:180–200.
   Google Scholar
• Saiphoklang N, Chomchoey C. Eosinophilia and parasitic infestations in patients with chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):12490. doi:10.1038/s41598-020-69541-7.
   PubMed Web of Science ®Google Scholar
• National Health Security Office. Seven risk groups to get free flu shots: influenza risk groups will get free flu shots from May 1 onward 2022; [ updated 2022 April 29; accessed 2022 June 20]. https://eng.nhso.go.th/view/1/home/News/436/EN-US.
   Google Scholar
• National Health Security Office. NHSO annual report year 2020; 2020 [ updated 2021 Sept 7; accessed 2022 June 20]. https://eng.nhso.go.th/view/1/Annual_Reports/EN-US.
   Google Scholar
• Gamil A, Chokephaibulkit K, Phongsamart W, Techasaensiri C, Piralam B, Thamaree R. Pneumococcal disease in Thailand. Int J Infect Dis. 2021;102:429–436. doi:10.1016/j.ijid.2020.10.048.
   PubMed Web of Science ®Google Scholar
• Infectious Disease Association of Thailand. Recommended adult and elderly immunization schedule: Department of Disease Control Ministry of Public Health; 2018 [accessed 2022 June 20]. https://ddc.moph.go.th/uploads/ckeditor/c20ad4d76fe97759aa27a0c99bff6710/files/adult.pdf.
   Google Scholar
• Thewjitcharoen Y, Butadej S, Malidaeng A, Yenseung N, Nakasatien S, Lekpittaya N, et al. Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010-2018: experience from a tertiary diabetes center in Bangkok. J Clin Transl Endocrinol. 2020;20:100227. doi:10.1016/j.jcte.2020.100227.
   PubMedGoogle Scholar
• Chiatti C, Barbadoro P, Marigliano A, Ricciardi A, Di Stanislao F, Prospero E. Determinants of influenza vaccination among the adult and older Italian population with chronic obstructive pulmonary disease: a secondary analysis of the multipurpose ISTAT survey on health and health care use. Hum Vaccin. 2011;7(10):1021–1025. doi:10.4161/hv.7.10.16849.
   PubMed Web of Science ®Google Scholar
• Santos-Sancho JM, Jimenez-Trujillo I, Hernandez-Barrera V, Lopez-de Andres A, Carrasco-Garrido P, Ortega-Molina P, Jiménez-García R. Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD. Hum Vaccin Immunother. 2012;8(7):938–945. doi:10.4161/hv.20204.
   PubMed Web of Science ®Google Scholar
• Arabyat RM, Raisch DW, Bakhireva L. Influenza vaccination for patients with chronic obstructive pulmonary disease: implications for pharmacists. Res Social Adm Pharm. 2018;14(2):162–169. doi:10.1016/j.sapharm.2017.02.010.
   PubMed Web of Science ®Google Scholar
• Fan J, Cong S, Wang N, Lyu XL, Bao HL, Wang BH, et al. Pneumococcal vaccination rate in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014-2015. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:1028–1033. doi:10.3760/cma.j.cn112338-20200124-00056.
   PubMedGoogle Scholar
• Shin HY, Hwang HJ, Chung JH. Factors influencing influenza vaccination among patients with chronic obstructive pulmonary disease: a population-based cross-sectional study. Asia Pac J Public Health. 2017;29(7):560–568. doi:10.1177/1010539517735415.
   PubMed Web of Science ®Google Scholar
• Li A, Chan YH, Liew MF, Pandey R, Phua J. Improving influenza vaccination coverage among patients with COPD: a pilot project. Int J Chron Obstruct Pulmon Dis. 2019;14:2527–2533. doi:10.2147/COPD.S222524.
   PubMed Web of Science ®Google Scholar
• Chen XRC, Fu SN, Leung WK, Ng SWC, Kwan WYW, Wong TK, Chan PF, Wong MYM, Ko WKW, Liang J. Clinical audit on chronic obstructive pulmonary disease (COPD) management in primary care: a quality improvement project from Hong Kong. Int J Chron Obstruct Pulmon Dis. 2021;16:1901–1911. doi:10.2147/COPD.S304527.
   PubMed Web of Science ®Google Scholar
• Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006:CD002733. doi:10.1002/14651858.CD002733.pub2.
   PubMed Web of Science ®Google Scholar
• Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331(12):778–784. doi:10.1056/NEJM199409223311206.
   PubMed Web of Science ®Google Scholar
• Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58:1–52.
   PubMedGoogle Scholar
• Walters JA, Tang JN, Poole P, Wood-Baker R. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;1:CD001390. doi:10.1002/14651858.CD001390.pub4.
   PubMed Web of Science ®Google Scholar
• Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822–825.
   PubMed Web of Science ®Google Scholar
• Alfageme I, Vazquez R, Reyes N, Munoz J, Fernandez A, Hernandez M, et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax. 2006;61(3):189–195. doi:10.1136/thx.2005.043323.
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Harnden S, Burton RL, Albert RK, Bailey WC, Casaburi R, et al. Long-Term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin Infect Dis. 2012;55(5):e35–44. doi:10.1093/cid/cis513.
   PubMed Web of Science ®Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AMM, Sanders EAM, Verheij TJM. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114–1125. doi:10.1056/NEJMoa1408544.
   PubMed Web of Science ®Google Scholar